Huwart A, et al. - This research incorporated an investigation of the inflammatory changes in patients taking tocilizumab for polymyalgia rheumatica (PMR), with the aid of ultrasound (US) and magnetic resonance imaging (MRI). Data shed light on substantial improvements in the inflammatory lesions as revealed via US and MRI during tocilizumab therapy for PMR.